Get in touch

Value and evidence.

Scroll

What we do.

We support Medical and Access professionals along the entire commercialization pathway for all forms of novel medical intervention valuable to patients and healthcare systems – including drugs, vaccines, devices, diagnostics, and technologies.

We provide a truly integrated approach from strategic planning to tactical execution based on interdependent and mutually informative workflows:

  • Pricing and market access (P&MA) strategy
  • Value communications
  • Evidence generation
  • Health Economics and Outcomes Research (HEOR) & Real-World Evidence (RWE) technical expertise

How we can help.

We work across the product development lifecycle to support distinct evidence and Market Access needs, supporting evidence strategy and generation through communications and training

  • Strategic analyses, including competitor intelligence, market situation, landscape
  • Integrated evidence planning & generation
  • Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) study design
  • HEOR/RWE advisory boards, steering committees
  • Evidence search, systematic literature reviews, network meta-analyses
  • Patient-reported outcome (PRO) assessments
  • Payer receptiveness testing
  • Value story and payer communications
  • Strategic HEOR/RWE publications planning and management
  • Design, development, and facilitation of comprehensive training courses

We combine skill and knowledge from experienced consultants with the latest AI-based technological platforms to produce insight and evidence-based solutions to Evidence and Access challenges.

We know that successful, timely publication of HEOR/RWE evidence can be challenging. That’s why our team is led by experienced health economists who not only understand the full range of HEOR and RWE study types but also have an innate ability to distill those highly technical concepts into a compelling and impactful narrative.

Meet the value & evidence team.

Headshot of Sarah Waterson, PhD

Sarah Waterson, PhD

Evidence Strategy & Value Lead

Headshot of Phil Wakefield, DPhil

Phil Wakefield, DPhil

Global Chief Advisory Services Officer

Read bio

Latest thinking across MEDiSTRAVA.

We are thought leaders in the industry, driving the conversation and challenging our peers.

Read more about what our experts have to say.

View all insights

Related solutions.

Explore practice areas

Medical strategy and excellence

We design and deliver custom approaches to accelerate the achievement of your goals and drive transformation within Medical Affairs.
Read more

Patient engagement

Our dedicated team of patient engagement specialists supports pharmaceutical and biotech companies to authentically engage with patient communities and incorporate the patient voice across all stages of medicine development and beyond.
Read more

Clinical trial optimization

With advanced expertise in complex scenarios, our Clinical Trials Optimization team provides end-to-end support from design to recruitment to real-world implementation.
Read more

Medical analytics & innovation

Never before has there been a time when more robust data, content, and opinions are readily at our disposal. Medical Analytics and Innovation operate at the center of this, working to turn an information deluge into actionable insight.
Read more

Corporate and investor communications

Our highly experienced Strategic Corporate and Financial Communications team works with innovative life sciences companies at all stages of growth and development.
Read more
Show previous slide
Show next slide

Contact us.

Learn more about MEDiSTRAVA’s strategic solutions and how we can help your business tackle the unique and evolving needs of leadership and Medical teams.

Speak to one of our specialists